+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Screening Market by Test Type, Technology, End User, Sample Type, Testing Mode - Global Forecast to 2030- Product Image
Blood Screening Market by Test Type, Technology, End User, Sample Type, Testing Mode - Global Forecast to 2030- Product Image
Sale

Blood Screening Market by Test Type, Technology, End User, Sample Type, Testing Mode - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083561
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The blood screening market is rapidly adapting to evolving demands in healthcare, with industry stakeholders focusing on technology-driven accuracy, compliance, and operational efficiency. Senior decision-makers today require reliable insights that translate complex market shifts into actionable strategy across regulatory, operational, and technological fronts.

Market Snapshot: Blood Screening Market

The Blood Screening Market grew from USD 5.31 billion in 2024 to USD 5.79 billion in 2025. It is expected to continue growing at a CAGR of 8.84%, reaching USD 8.83 billion by 2030.

Scope & Segmentation of the Blood Screening Market

This analysis offers a comprehensive view of the blood screening sector, providing focused segmentation by test type, technologies, end users, sample categories, and regional markets. Senior leaders can quickly identify priority areas based on operational mandates, geographic presence, and long-term investment plans.

  • Test Types: Hepatitis B Screening, Hepatitis C Screening, HIV Screening, Syphilis Screening
  • Technology: Chemiluminescence, Flow Cytometry, Immunoassays (Chemiluminescence Immunoassay, Enzyme Linked Immunosorbent Assay, Radioimmunoassay), Molecular Diagnostics (Isothermal Amplification, Next Generation Sequencing, Polymerase Chain Reaction)
  • End Users: Blood Banks, Clinics, Diagnostic Laboratories, Hospitals
  • Sample Types: Plasma, Serum, Whole Blood
  • Testing Modes: Lab Based, Point Of Care
  • Geographic Coverage: Americas (with key states in the United States), Europe, Middle East & Africa (including major European economies and emerging healthcare systems), Asia-Pacific (with rapid technology adoption)
  • Key Companies Profiled: F. Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Grifols S.A., Bio-Rad Laboratories Inc., Ortho Clinical Diagnostics Inc., Hologic Inc., Terumo BCT Inc.

Key Takeaways for Decision-Makers

  • Strategic investments in automation and digitalization are transforming laboratory workflows, improving accuracy, and reducing turnaround times.
  • Elevated regulatory expectations and harmonization are prompting laboratories to enhance sensitivity and throughput in blood screening processes.
  • Expansion of point of care testing supports decentralized blood screening, expanding reach to underserved and remote regions.
  • The integration of molecular diagnostics with legacy methods is enabling deeper pathogen insights alongside traditional immunoassays.
  • Collaboration between producers, public health agencies, and academic institutions is accelerating adoption of emerging screening technologies and formats.
  • Regional supply chain approaches and local partnerships are increasingly critical for adaptability and resilience against external market shocks.

2025 US Tariff Impact on Blood Screening Supply Chains

Ongoing tariff policies in the United States have created cost pressures for imported blood screening reagents, consumables, and equipment. Manufacturers are shifting focus to domestic production and regionalized supply chains to mitigate elevated duties and sustain supply continuity. Stakeholders must proactively manage procurement strategies, anticipate budget adjustments, and ensure transparency across their networks to maintain service stability while navigating these trade-related uncertainties.

Methodology & Data Sources

Research findings stem from a rigorous mix of primary interviews and secondary data review. Inputs include industry reports, regulatory filings, company documentation, and discussions with laboratory leaders. Data triangulation, expert peer review, and proprietary databases underpin the reliability and depth of this analysis.

Why This Report Matters

  • Enables executives to optimize strategic planning with unique insights into the segmented dynamics and evolving trends of the blood screening market.
  • Provides a data-backed framework for evaluating supply chain and technology investments amid industry disruption and regulatory evolution.
  • Assists with benchmarking partner and competitor actions, supporting proactive resource allocation and risk mitigation strategies.

Conclusion

This executive summary equips decision-makers with concise, actionable insights into the evolving blood screening market. Leaders can leverage this foundation to refine competitive strategies and strengthen resilience in a rapidly changing global landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Screening Market, by Test Type
8.1. Introduction
8.2. Hepatitis B Screening
8.3. Hepatitis C Screening
8.4. HIV Screening
8.5. Syphilis Screening
9. Blood Screening Market, by Technology
9.1. Introduction
9.2. Chemiluminescence
9.3. Flow Cytometry
9.4. Immunoassays
9.4.1. Chemiluminescence Immunoassay
9.4.2. Enzyme Linked Immunosorbent Assay
9.4.3. Radioimmunoassay
9.5. Molecular Diagnostics
9.5.1. Isothermal Amplification
9.5.2. Next Generation Sequencing
9.5.3. Polymerase Chain Reaction
10. Blood Screening Market, by End User
10.1. Introduction
10.2. Blood Banks
10.3. Clinics
10.4. Diagnostic Laboratories
10.5. Hospitals
11. Blood Screening Market, by Sample Type
11.1. Introduction
11.2. Plasma
11.3. Serum
11.4. Whole Blood
12. Blood Screening Market, by Testing Mode
12.1. Introduction
12.2. Lab Based
12.3. Point Of Care
13. Americas Blood Screening Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Blood Screening Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Blood Screening Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Abbott Laboratories
16.3.3. Siemens Healthineers AG
16.3.4. Danaher Corporation
16.3.5. Thermo Fisher Scientific Inc.
16.3.6. Grifols, S.A.
16.3.7. Bio-Rad Laboratories, Inc.
16.3.8. Ortho Clinical Diagnostics, Inc.
16.3.9. Hologic, Inc.
16.3.10. Terumo BCT, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BLOOD SCREENING MARKET MULTI-CURRENCY
FIGURE 2. BLOOD SCREENING MARKET MULTI-LANGUAGE
FIGURE 3. BLOOD SCREENING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD SCREENING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BLOOD SCREENING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BLOOD SCREENING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BLOOD SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY HEPATITIS B SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY HEPATITIS C SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY HIV SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY SYPHILIS SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD SCREENING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD SCREENING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD SCREENING MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD SCREENING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD SCREENING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD SCREENING MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD SCREENING MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD SCREENING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD SCREENING MARKET SIZE, BY LAB BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD SCREENING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. CANADA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. CANADA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 55. CANADA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 56. CANADA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. CANADA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 58. CANADA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 60. MEXICO BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. MEXICO BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 63. MEXICO BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. MEXICO BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. GERMANY BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 98. GERMANY BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 99. GERMANY BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. GERMANY BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 101. GERMANY BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 102. FRANCE BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 103. FRANCE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. FRANCE BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 105. FRANCE BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 106. FRANCE BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. FRANCE BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 108. FRANCE BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 116. ITALY BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 117. ITALY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. ITALY BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 119. ITALY BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 120. ITALY BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. ITALY BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 122. ITALY BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 123. SPAIN BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 124. SPAIN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. SPAIN BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 126. SPAIN BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 127. SPAIN BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. SPAIN BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 143. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 150. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 151. DENMARK BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 152. DENMARK BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. DENMARK BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 154. DENMARK BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 155. DENMARK BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. DENMARK BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 157. DENMARK BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 165. QATAR BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 166. QATAR BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. QATAR BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 168. QATAR BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 169. QATAR BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. QATAR BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 171. QATAR BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 172. FINLAND BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 173. FINLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. FINLAND BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 175. FINLAND BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 176. FINLAND BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. FINLAND BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 178. FINLAND BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 185. SWEDEN BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 192. NIGERIA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 193. EGYPT BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 194. EGYPT BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. EGYPT BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 196. EGYPT BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 197. EGYPT BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. EGYPT BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 199. EGYPT BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 200. TURKEY BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 201. TURKEY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. TURKEY BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 203. TURKEY BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 204. TURKEY BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. TURKEY BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 206. TURKEY BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 214. NORWAY BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 215. NORWAY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. NORWAY BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 217. NORWAY BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 218. NORWAY BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. NORWAY BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 220. NORWAY BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 221. POLAND BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 222. POLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 223. POLAND BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 224. POLAND BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 225. POLAND BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. POLAND BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 227. POLAND BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 243. CHINA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 244. CHINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. CHINA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 246. CHINA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 247. CHINA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. CHINA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 249. CHINA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 250. INDIA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 251. INDIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. INDIA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 253. INDIA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 254. INDIA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. INDIA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 256. INDIA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 257. JAPAN BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 258. JAPAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. JAPAN BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 260. JAPAN BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 261. JAPAN BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. JAPAN BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 263. JAPAN BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 277. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 285. THAILAND BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 286. THAILAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. THAILAND BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 288. THAILAND BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 289. THAILAND BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. THAILAND BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 291. THAILAND BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 298. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. SINGAPORE BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 312. SINGAPORE BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. VIETNAM BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 319. VIETNAM BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. TAIWAN BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 326. TAIWAN BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2030 (USD MILLION)
TABLE 327. BLOOD SCREENING MARKET SHARE, BY KEY PLAYER, 2024
TABLE 328. BLOOD SCREENING MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Blood Screening market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Grifols, S.A.
  • Bio-Rad Laboratories, Inc.
  • Ortho Clinical Diagnostics, Inc.
  • Hologic, Inc.
  • Terumo BCT, Inc.

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.79 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.83 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Blood Screening Market Size, Share & Trends Analysis Report by Technology (Nucleic Acid Amplification Test, ELISA, Western Blotting), Product (Reagent, Instrument), Region, and Segment Forecasts, 2025-2030 - Product Image

Blood Screening Market Size, Share & Trends Analysis Report by Technology (Nucleic Acid Amplification Test, ELISA, Western Blotting), Product (Reagent, Instrument), Region, and Segment Forecasts, 2025-2030

  • Report
  • 90 Pages
  • Global
From
Blood Screening Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Image

Blood Screening Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • 187 Pages
  • Global
From
Blood Screening - Global Strategic Business Report - Product Image

Blood Screening - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Blood Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Blood Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 210 Pages
  • Global
From
Blood Screening Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Blood Screening Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 156 Pages
  • Global
From

About the Blood Screening Market

The Blood Screening market within the context of In Vitro Diagnostics is a rapidly growing sector of the healthcare industry. It involves the use of laboratory tests to detect and diagnose diseases and other medical conditions. These tests are used to detect a wide range of conditions, including infections, genetic disorders, and cancer. Blood screening tests are used to detect the presence of antibodies, antigens, and other markers that can indicate the presence of a disease or condition. Blood screening tests are used in a variety of settings, including hospitals, clinics, and laboratories. They are also used in research and development, as well as in the development of new treatments and therapies. Blood screening tests are used to monitor the health of patients, as well as to detect and diagnose diseases and other medical conditions. Some of the major companies in the Blood Screening market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. These companies provide a wide range of products and services, including diagnostic tests, reagents, and instruments. They also offer a variety of services, such as consulting, training, and support. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.